Thymosin Beta-4 (TB-500 Fragment)
TB-500 | TB500 | Thymosin Beta 4 | Tbeta4
Mechanism of Action
Thymosin beta-4 (Tbeta4) is a 43-amino-acid peptide that is the most abundant member of the beta-thymosin family. Despite its name (a historical artifact from its original isolation from thymus tissue), Tbeta4 is expressed in virtually all nucleated cells and is one of the most abundant intracellular peptides, with concentrations reaching 0.4 mM in some cell types. TB-500 is a synthetic version commonly used in research.
The primary intracellular function of Tbeta4 is sequestration of G-actin (globular, monomeric actin), regulating the pool of actin available for polymerization into F-actin (filamentous actin). This function is critical because actin polymerization drives cell migration — a rate-limiting step in wound healing. By maintaining a reserve of polymerization-ready G-actin, Tbeta4 enables rapid cell migration when needed. The active site responsible for actin binding is the central region containing the sequence LKKTET.
Beyond actin regulation, Tbeta4 has potent anti-inflammatory activity. It suppresses NF-kB signaling and reduces pro-inflammatory cytokine expression. Bock-Marquette et al. made a landmark discovery showing Tbeta4 activates Akt (protein kinase B) in cardiomyocytes, promoting survival after ischemic injury. This finding opened research into cardiac repair applications. Tbeta4 also promotes angiogenesis, hair follicle stem cell migration, and has been shown to reduce corneal inflammation and scarring.
Key Research Findings
- Malinda et al. (1999) demonstrated Tbeta4 accelerated dermal wound healing in rats, promoting keratinocyte migration and angiogenesis while reducing inflammation.
- Bock-Marquette et al. (2004) showed Tbeta4 promotes survival of cardiomyocytes after ischemic injury through Akt activation, establishing its cardioprotective potential.
- Philp et al. (2004) demonstrated Tbeta4 promotes corneal wound healing by stimulating epithelial cell migration and reducing inflammatory infiltrates and scarring.
- Sosne et al. (2007) showed Tbeta4 suppresses NF-kB activation and downstream inflammatory mediators, providing a mechanism for its anti-inflammatory effects.
- Smart et al. (2007) demonstrated Tbeta4 activates epicardial progenitor cells to form new cardiomyocytes in adult mouse hearts, suggesting regenerative cardiac potential.
References
Dosage in Research
Equine research used loading doses of 10 mg every other day for 30 days. Rodent wound healing studies used 5-6 mcg/wound topically or 150 mcg systemically. Cardiac studies in mice used 150 mcg intraperitoneally.
Storage & Handling
Store lyophilized powder at -20C. Reconstituted solution should be refrigerated at 2-8C and used within 21 days. Tbeta4 is moderately stable in solution.
Frequently Asked Questions
What is TB-500/Thymosin Beta-4?
Thymosin beta-4 is a naturally occurring 43-amino-acid peptide found in nearly all human cells. It regulates actin polymerization (critical for cell migration), promotes wound healing, reduces inflammation, and has shown cardioprotective properties. TB-500 is a commonly used synthetic form.
How does TB-500 promote wound healing?
TB-500 primarily works by regulating actin availability for cell migration — the rate-limiting step in wound repair. It maintains a pool of G-actin ready for rapid polymerization, enabling keratinocytes and fibroblasts to migrate into wound sites. It also promotes angiogenesis and suppresses inflammation via NF-kB inhibition.
What is the LKKTET sequence?
LKKTET is the actin-binding domain within thymosin beta-4. This six-amino-acid sequence is responsible for G-actin sequestration and is considered the minimal active sequence for many of TB4's biological effects.
Source Thymosin Beta-4 (TB-500 Fragment) for your research
98%+ purity, third-party tested, COA included